Security
Edesa Biotech, Inc. Common Shares · EDSA
EDSANASDAQCommon stockCurrentCIK 1540159Updated Oct 30, 2026
Name history
Stellar Biotechnologies, Inc. · through May 30, 2019
EDSA price & chart
Loading TradingView…
NASDAQ:EDSA on TradingView ↗In the news
Edesa Biotech Announces Proposed Public Offering ↗
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors ↗
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference ↗
Seeking Alpha
Edesa Biotech prices $25M equity offering ↗
Edesa Biotech, Inc. (EDSA) Presents at Dermatology Drug Development Summit 2026 - Slideshow ↗
Edesa Biotech, Inc. (EDSA) Presents at Respiratory Innovation Summit 2026 - Slideshow ↗
SEC disclosures
Edesa Biotech, Inc. files 8-K: Material Event ↗
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Other Events
Items 8.01
4 filing
SCHEDULE 13D/A - filed by Nijhawan Pardeep regarding Edesa Biotech, Inc.
SCHEDULE 13D/A - filed by Velan Capital Investment Management LP regarding Edesa Biotech, Inc.
Show 5 more recent filings
Entry into a Material Definitive Agreement · Other Events
Items 1.01, 8.01, 9.01
424B5 filing
424B5 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 12,721,195Source | 14,804,800Source | 5,227,722Source | 12,384,738Source | 16,454,299Source | 6,475,056Source | 14,710,442Source | 4,164,181Source | 13,530,518Source | 3,813,982Source | 8,890,437Source | 11,575,728Source |
| Property, Plant and Equipment, NetUSD | — | — | 0Source | — | — | 7,365Source | — | — | — | 0Source | 8,702Source | 12,694Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 10,300,000Source | 12,400,000Source | — | 10,000,000Source | 13,900,000Source | — | 12,100,000Source | 1,600,000Source | 10,800,000Source | 1,000,000Source | 5,400,000Source | 7,090,919Source |
| Assets, CurrentUSD | 10,780,278Source | 12,761,092Source | 3,046,634Source | 10,417,727Source | 14,387,289Source | 4,242,218Source | 12,717,487Source | 2,071,928Source | 11,512,876Source | 1,675,622Source | 6,436,852Source | 9,091,913Source |
| Prepaid Expense and Other Assets, CurrentUSD | 219,707Source | 112,659Source | 454,686Source | 197,576Source | 108,199Source | 330,267Source | 234,414Source | 157,787Source | 77,838Source | 367,394Source | 448,912Source | 745,543Source |
| Operating Lease, Right-of-Use AssetUSD | — | 0Source | 36,286Source | — | 0Source | 54,972Source | — | 0Source | 0Source | 18,361Source | 91,373Source | 18,465Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | — | — | 2,360,627Source | — | — | 2,150,723Source | — | — | — | 1,832,827Source | 1,841,637Source | 2,184,439Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 62,416,047Source | 54,271,112Source | 47,236,024Source | 58,932,825Source | 54,271,112Source | 47,136,168Source | 57,899,593Source | 47,562,091Source | 54,515,421Source | 47,236,024Source | — | — |
| Additional Paid in CapitalUSD | 16,037,835Source | 14,406,511Source | 13,482,824Source | 15,526,657Source | 14,229,130Source | 13,373,318Source | 15,124,219Source | 14,176,399Source | 14,753,110Source | 13,576,757Source | 13,039,265Source | 11,176,345Source |
| Retained Earnings (Accumulated Deficit)USD | -77,896,367Source | -63,645,218Source | -57,626,962Source | -72,451,359Source | -61,858,769Source | -55,958,750Source | -68,196,040Source | -60,231,745Source | -65,910,974Source | -58,589,013Source | -52,418,968Source | -44,044,553Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -158,541Source | -123,077Source | -224,791Source | -186,089Source | -287,688Source | -226,403Source | -171,086Source | -223,957Source | -165,771Source | -242,613Source | -214,648Source | -213,602Source |
| Stockholders' Equity Attributable to ParentUSD | 8,811,154Source | 14,132,126Source | 2,867,095Source | 10,196,817Source | 15,539,598Source | 4,324,333Source | 13,954,279Source | 2,263,962Source | 12,451,982Source | 1,981,155Source | 7,048,800Source | 9,391,289Source |
| Liabilities and EquityUSD | 12,721,195Source | 14,804,800Source | 5,227,722Source | 12,384,738Source | 16,454,299Source | 6,475,056Source | 14,710,442Source | 4,164,181Source | 13,530,518Source | 3,813,982Source | 8,890,437Source | 11,575,728Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 3,910,041Source | 672,674Source | 2,360,627Source | 2,187,921Source | 914,701Source | 2,150,723Source | 756,163Source | 1,900,219Source | 1,078,536Source | 1,832,827Source | 1,821,864Source | 2,140,777Source |
| Operating Lease, Liability, CurrentUSD | — | 0Source | 38,817Source | — | 0Source | 58,143Source | — | 0Source | 0Source | 19,867Source | 74,714Source | 18,975Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | 0Source | — | — | 0Source | — | — | — | 0Source | 19,773Source | 0Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 131,000Source | 126,000Source | 233,000Source | 36,000Source |
| Preferred Stock, Value, Issued | — | — | — | — | — | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | 8,374,415Source | 17,548,924Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 25,460Source | 43,109Source | 119,273Source | 186,049Source | 183,471Source | 118,188Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 399,862Source | 81,183Source | 729,642Source | 537,492Source | 1,246,457Source | 2,260,634Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | — | — | — | — | 2,027,454Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,087,334Source | -1,517,203Source | -7,322,262Source | -4,890,205Source | -6,636,483Source | -12,279,302Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | 0Source | -5,656Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 5,656Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,355,419Source | 2,071,545Source | 17,030,898Source | 592,031Source | 4,830,111Source | 11,629,628Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 1,259,576Source | 526,182Source | 9,754,852Source | -4,324,077Source | -1,729,522Source | -748,340Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 10,332,520Source | 12,361,690Source | 10,003,683Source | 13,896,650Source | 12,051,748Source | 1,563,502Source | 10,792,172Source | 1,037,320Source | 5,361,397Source | 7,090,919Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | — | — | — | — | 76,850Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 500,000Source | 200,000Source | 480,000Source | 70,000Source | 400,000Source | 80,000Source | 700,000Source | 500,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 101,172,000,000Source | 101,172,000,000Source | 1,011,720,000Source | 1,011,720,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | — | 8,702Source | 4,328,000,000Source | 6,991,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 4,295Source | -29,574Source | 12,595Source | -3,295Source | -8,758Source | -21,425Source | -59,609Source | -21,042Source | -21,742Source | -21,114Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | 0Source | 14,766Source | — | — |
| General and Administrative ExpenseUSD | — | — | 1,561,674Source | 964,676Source | 1,529,906Source | 1,154,580Source | 1,216,656Source | 878,871Source | 4,242,828Source | 4,132,777Source | 4,428,209Source | 5,035,456Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 800Source | 800Source | — | — | 800Source | 800Source | 800Source | 800Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,407,611Source | -1,749,464Source | -4,218,332Source | -1,590,448Source | -2,247,669Source | -1,617,253Source | -7,185,523Source | -6,170,045Source | -8,374,415Source | -17,548,924Source |
| Nonoperating Income (Expense)USD | — | — | 111,938Source | 154,279Source | 79,462Source | 49,238Source | 93,714Source | 281,436Source | 726,843Source | 845,499Source | 849,143Source | — |
| Operating Lease, Lease IncomeUSD | — | — | — | — | — | — | — | — | — | — | — | 780,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 3,497,825Source | 626,760Source | 7,717,634Source | 729,387Source | 4,345,017Source | 0Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -5,519,549Source | -1,903,743Source | -4,296,994Source | -1,638,886Source | -2,341,383Source | -1,898,689Source | -7,911,566Source | -7,014,744Source | -9,222,758Source | -18,370,790Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -5,407,611Source | -1,749,464Source | -4,217,532Source | -1,589,648Source | — | — | -7,184,723Source | -6,169,245Source | -8,373,615Source | -17,548,124Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 800Source | 800Source | — | — | 800Source | 800Source | 800Source | 800Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,407,611Source | -1,749,464Source | -4,218,332Source | -1,590,448Source | -2,247,669Source | -1,617,253Source | -7,185,523Source | -6,170,045Source | -8,374,415Source | -17,548,924Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.6Source | -0.25Source | -0.49Source | -0.3Source | -0.28Source | -0.48Source | -1.27Source | -1.93Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 9,007,474Source | 7,022,678Source | 8,541,146Source | 5,305,763Source | 7,972,532Source | 3,345,135Source | 5,676,708Source | 3,197,423Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 101,172,000,000Source | 101,172,000,000Source | 1,011,720,000Source | 1,011,720,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | — | — | — | — | 183,471Source | 118,188Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | 4,295Source | -29,574Source | 12,595Source | -3,295Source | -8,758Source | -21,425Source | -59,609Source | -21,042Source | -21,742Source | -21,114Source |
| General and Administrative ExpenseUSD | — | — | 1,561,674Source | 964,676Source | 1,529,906Source | 1,154,580Source | 1,216,656Source | 878,871Source | 4,242,828Source | 4,132,777Source | 4,428,209Source | 5,035,456Source |
| Interest Income, OtherUSD | — | — | 275Source | 572Source | 639Source | 265Source | 47Source | 1,666Source | 2,558Source | 153,498Source | 289,846Source | 63,523Source |
| Nonoperating Income (Expense)USD | — | — | 111,938Source | 154,279Source | 79,462Source | 49,238Source | 93,714Source | 281,436Source | 726,843Source | 845,499Source | 849,143Source | — |
| Operating Lease, Lease IncomeUSD | — | — | — | — | — | — | — | — | — | — | — | 780,000Source |
| Research and Development ExpenseUSD | — | — | 3,957,875Source | 939,067Source | 2,767,088Source | 484,306Source | 1,124,727Source | 1,019,818Source | 3,668,738Source | 2,881,967Source | 4,794,549Source | 13,335,334Source |
Offerings
Registration 333-297251
Filing attachments
d12147783_ex99-1.htm · SCHEDULE 13G · 2026-05-15
EXHIBIT 99.1 JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the …
Read attachment ↗